HMGB1 and colorectal carcinoma: It inhibits inflammation by binding HMGB1, suppresses proliferation and dedifferentiation of CSCs, and DNA damage via the HMGB1/TLR4/NF-κB pathway, suggesting its potential as a CRC preventive agent [73].